Literature DB >> 22422382

Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy.

Y J Suh1, M J Kim, E-K Kim, H J Moon, J Y Kwak, H R Koo, J H Yoon.   

Abstract

OBJECTIVE: The objective of this study was to compare the underestimation rate of invasive carcinoma in cases with ductal carcinoma in situ (DCIS) at percutaneous ultrasound-guided core biopsies of breast lesions between 14-gauge automated core-needle biopsy (ACNB) and 8- or 11-gauge vacuum-assisted biopsy (VAB), and to determine the relationship between the lesion type (mass or microcalcification on radiological findings) and the DCIS underestimation rate.
METHODS: We retrospectively reviewed imaging-guided biopsies of breast lesions performed from February 2003 to August 2008. 194 lesions were diagnosed as DCIS at ultrasound-guided core biopsy: 138 lesions in 132 patients by 14-gauge ACNB, and 56 lesions in 56 patients by 8- or 11-gauge VAB. The histological results of the core biopsy samples were correlated with surgical specimens. The clinical and radiological findings were also reviewed. The histological DCIS underestimation rates were compared between the two groups and were analysed for differences according to the clinical and radiological characteristics of the lesions.
RESULTS: The DCIS underestimation rate was 47.8% (66/138) for 14-gauge ACNB and 16.1% (9/56) for VAB (p<0.001). According to the lesion type on sonography, DCIS underestimation was 43.4% (63/145) in masses (47.6% using ACNB and 15.8% using VAB; p=0.012) and 24.5% (12/49) in microcalcifications (50.0% using ACNB and 16.2% using VAB; p=0.047).
CONCLUSION: The underestimation rate of invasive carcinoma in cases with DCIS at ultrasound-guided core biopsies was significantly higher for ACNB than for VAB. Furthermore, this difference does not change according to the lesion type on ultrasound. Therefore, ultrasound-guided VAB can be a useful method for the diagnosis of DCIS lesions presented as either mass or microcalcification.

Entities:  

Mesh:

Year:  2012        PMID: 22422382      PMCID: PMC3587071          DOI: 10.1259/bjr/30974918

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  36 in total

1.  Imaging-histologic discordance at percutaneous breast biopsy.

Authors:  L Liberman; M Drotman; E A Morris; L R LaTrenta; A F Abramson; M F Zakowski; D D Dershaw
Journal:  Cancer       Date:  2000-12-15       Impact factor: 6.860

2.  US of mammographically detected clustered microcalcifications.

Authors:  W K Moon; J G Im; Y H Koh; D Y Noh; I A Park
Journal:  Radiology       Date:  2000-12       Impact factor: 11.105

Review 3.  Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation.

Authors:  Sarah E Pinder
Journal:  Mod Pathol       Date:  2010-05       Impact factor: 7.842

4.  Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.

Authors:  R J Jackman; F Burbank; S H Parker; W P Evans; M C Lechner; T R Richardson; A A Smid; H B Borofsky; C H Lee; H M Goldstein; K J Schilling; A B Wray; R F Brem; T H Helbich; D E Lehrer; S J Adler
Journal:  Radiology       Date:  2001-02       Impact factor: 11.105

5.  Sonographically guided biopsy of suspicious microcalcifications of the breast: a pilot study.

Authors:  Mary Scott Soo; Jay A Baker; Eric L Rosen; Thuy T Vo
Journal:  AJR Am J Roentgenol       Date:  2002-04       Impact factor: 3.959

6.  The utility of ultrasonographically guided large-core needle biopsy: results from 500 consecutive breast biopsies.

Authors:  D N Smith; M L Rosenfield Darling; J E Meyer; C M Denison; D I Rose; S Lester; A Richardson; C M Kaelin; E Rhei; R L Christian
Journal:  J Ultrasound Med       Date:  2001-01       Impact factor: 2.153

7.  Sonographic appearance of ductal carcinoma in situ diagnosed with ultrasonographically guided large core needle biopsy: correlation with mammographic and pathologic findings.

Authors:  J M Schoonjans; R F Brem
Journal:  J Ultrasound Med       Date:  2000-07       Impact factor: 2.153

8.  Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision.

Authors:  M L Darling; D N Smith; S C Lester; C Kaelin; D L Selland; C M Denison; P J DiPiro; D I Rose; E Rhei; J E Meyer
Journal:  AJR Am J Roentgenol       Date:  2000-11       Impact factor: 3.959

9.  Fourteen-gauge ultrasonographically guided large-core needle biopsy of breast masses.

Authors:  J M Schoonjans; R F Brem
Journal:  J Ultrasound Med       Date:  2001-09       Impact factor: 2.153

10.  Comparison of automated versus vacuum-assisted biopsy methods for sonographically guided core biopsy of the breast.

Authors:  Liane E Philpotts; Regina J Hooley; Carol H Lee
Journal:  AJR Am J Roentgenol       Date:  2003-02       Impact factor: 3.959

View more
  11 in total

1.  Non-mass-like lesions on breast ultrasound: classification and correlation with histology.

Authors:  Zhi Li Wang; Nan Li; Min Li; Wen Bo Wan
Journal:  Radiol Med       Date:  2015-03-01       Impact factor: 3.469

Review 2.  The Evolving Role of Vacuum Assisted Biopsy of the Breast: A Progression from Fine-Needle Aspiration Biopsy.

Authors:  Ian C Bennett; Apoorva Saboo
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

3.  Percutaneous ultrasound-guided vacuum-assisted removal versus surgery for breast lesions showing imaging-histology discordance after ultrasound-guided core-needle biopsy.

Authors:  Yu-Mee Sohn; Jung Hyun Yoon; Eun-Kyung Kim; Hee Jung Moon; Min Jung Kim
Journal:  Korean J Radiol       Date:  2014-11-07       Impact factor: 3.500

4.  Does Mammotome biopsy affect surgery option and margin status of breast conserving surgery in breast cancer?

Authors:  Yanan Kong; Ning Lyu; Jianwei Wang; Yan Wang; Ya Sun; Zeming Xie; Peng Liu
Journal:  Gland Surg       Date:  2021-08

5.  A comparison of diagnostic performance of vacuum-assisted biopsy and core needle biopsy for breast microcalcification: a systematic review and meta-analysis.

Authors:  Xu Chen Huang; Xu Hua Hu; Xiao Ran Wang; Chao Xi Zhou; Fei Fei Wang; Shan Yang; Gui Ying Wang
Journal:  Ir J Med Sci       Date:  2018-03-16       Impact factor: 1.568

6.  The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.

Authors:  Christine Tunon-de-Lara; Marie Pierre Chauvet; Marie Christine Baranzelli; Marc Baron; Jean Piquenot; Guillaume Le-Bouédec; Fréderique Penault-Llorca; Jean-Rémi Garbay; Jérôme Blanchot; Joëlle Mollard; Véronique Maisongrosse; Simone Mathoulin-Pélissier; Gaëtan MacGrogan
Journal:  Ann Surg Oncol       Date:  2015-03-17       Impact factor: 5.344

7.  Ultrasonography-guided 14-gauge core biopsy of the breast: results of 7 years of experience.

Authors:  Inha Jung; Min Jung Kim; Hee Jung Moon; Jung Hyun Yoon; Eun-Kyung Kim
Journal:  Ultrasonography       Date:  2017-05-17

8.  Ultrasound-guided cable-free 13-gauge vacuum-assisted biopsy of non-mass breast lesions.

Authors:  Jiwoon Seo; Sun Mi Kim; Mijung Jang; Bo La Yun; Soo Hyun Lee; Eun-Kyu Kim; Eunyoung Kang; So Yeon Park; Woo Kyung Moon; Hye Young Choi; Bohyoung Kim
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

9.  Ultrasound-guided vacuum-assisted breast biopsy with a small-caliber device: A multicenter consecutive study of 162 biopsied lesions.

Authors:  Christophe Tourasse; Elina Khasanova; Philippe Sebag; Jean Paul Beregi
Journal:  Tumori       Date:  2018-07-09       Impact factor: 2.098

10.  An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast.

Authors:  Sanghwa Kim; Jihong Kim; Hyung Seok Park; Ha Yan Kim; Kwanbum Lee; Jeea Lee; Haemin Lee; Jee Ye Kim; Seung Il Kim; Young Up Cho; Byeong Woo Park
Journal:  Yonsei Med J       Date:  2019-11       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.